{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:11:56Z","timestamp":1783548716830,"version":"3.55.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/33\/2019-NAN-BMS"],"award-info":[{"award-number":["45\/33\/2019-NAN-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bone.2025.117526","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:21:21Z","timestamp":1747718481000},"page":"117526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice"],"prefix":"10.1016","volume":"198","author":[{"given":"Nikita","family":"Nirwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreshta","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0005","first-page":"92","article-title":"Osteoporosis: a review of treatment options","volume":"43","author":"Tu","year":"2018","journal-title":"P & T"},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0010","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-15-0118","article-title":"Management of endocrine disease: secondary osteoporosis: pathophysiology and management","volume":"173","author":"Mirza","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"43","key":"10.1016\/j.bone.2025.117526_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008294","article-title":"Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: a cross-sectional study in Gansu province, northwestern of China","volume":"96","author":"Tian","year":"2017","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/jmh.jmh_114_22","article-title":"Prevalence of osteoporosis and associated risk factors among postmenopausal women: a cross-sectional study from northern India","volume":"13","author":"Imran","year":"2022","journal-title":"Journal of Mid-Life Health"},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2015.01.010","article-title":"Osteoporosis: screening, prevention, and management","volume":"99","author":"Golob","year":"2015","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bone.2025.117526_bb0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.12688\/f1000research.10682.1","article-title":"Recent advances in the management of osteoporosis","volume":"6","author":"Fukumoto","year":"2017","journal-title":"F1000Res"},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.berh.2009.09.006","article-title":"Secondary osteoporosis in patients with an osteoporotic fracture","volume":"23","author":"Kok","year":"2009","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2025.117526_bb0040","unstructured":"Ilias, I., Milionis, C., Zoumakis, E. An overview of glucocorticoid-induced osteoporosis, in: Feingold, K.R., Ahmed, S.F., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herr, W.W., Dhatariya, K., Dungan, K., Hofland, J., Kalra, S., Kaltsas, G., Kapoor, N., Koch, C., Kopp, P., Korbonits, M., Kovacs, C.S., Kuohung, W., Laferr\u00e8re, B., Levy, M., McGee, E.A., McLachlan, R., Muzumdar, R., Purnell, J., Rey, R., Sahay, R., Shah, A.S., Singer, F., Sperling, M.A., Stratakis, C.A., Trence, D.L., Wilson, D.P. (Eds.), Endotext, MDText.com, Inc."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-023-01246-6","article-title":"Prevalence of glucocorticoid-induced osteoporosis among rheumatology patients in Africa: a systematic review and meta-analysis","volume":"18","author":"Hmamouchi","year":"2023","journal-title":"Arch. Osteoporos."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng.284","article-title":"New sequence variants associated with bone mineral density","volume":"41","author":"Styrkarsdottir","year":"2009","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.bone.2025.117526_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcp.24487","article-title":"TNF-\u03b1 upregulates sclerostin expression in obese mice fed a high-fat diet","volume":"229","author":"Baek","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0065","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.bone.2025.117526_bb0075","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.bone.2025.117526_bb0085","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2008.08.034","article-title":"Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression","volume":"375","author":"Kanazawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2025.117526_bb0095","doi-asserted-by":"crossref","first-page":"5923818","DOI":"10.1155\/2017\/5923818","article-title":"Corrigendum to \u201cmetformin decreases reactive oxygen species, enhances osteogenic properties of adipose-derived multipotent mesenchymal stem cells in vitro, and increases bone density in vivo\u201d","volume":"2017","author":"Marycz","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejphar.2011.07.033","article-title":"Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats","volume":"668","author":"Sedlinsky","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.090732","article-title":"Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies","volume":"25","author":"Molinuevo","year":"2010","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0110","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/17446651.2020.1831911","article-title":"Update on: effects of anti-diabetic drugs on bone metabolism","volume":"15","author":"Mabilleau","year":"2020","journal-title":"Expert Review of Endocrinology & Metabolism"},{"key":"10.1016\/j.bone.2025.117526_bb0120","article-title":"SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: a nationwide cohort study","volume":"13","author":"Al-Mashhadi","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2025.117526_bb0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00223-018-0507-0","article-title":"Sitagliptin alters bone composition in high-fat-fed mice","volume":"104","author":"Mansur","year":"2019","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0130","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","article-title":"Dpp iv inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats","volume":"307","author":"Glorie","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/en.2010-1098","article-title":"Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice","volume":"152","author":"Kyle","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/21655979.2021.1900633","article-title":"Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis","volume":"12","author":"Shao","year":"2021","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.bone.2025.117526_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168569","article-title":"Protective effects of Vildagliptin against pioglitazone-induced bone loss in type 2 diabetic rats","volume":"11","author":"Eom","year":"2016","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/dom.12109","article-title":"Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione","volume":"15","author":"Cusick","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bone.2025.117526_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fphar.2017.00407","article-title":"Sitagliptin, an anti-diabetic drug, suppresses estrogen deficiency-induced osteoporosis in vivo and inhibits rankl-induced osteoclast formation and bone resorption in vitro","volume":"8","author":"Wang","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/j.bone.2025.117526_bb0160","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0165","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2015-4180","article-title":"Does sitagliptin affect the rate of osteoporotic fractures in type 2 diabetes? Population-based cohort study","volume":"101","author":"Majumdar","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2025.117526_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187537","article-title":"The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials","volume":"12","author":"Yang","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bone.2025.117526_bb0175","doi-asserted-by":"crossref","first-page":"8874272","DOI":"10.1155\/2020\/8874272","article-title":"DPP4 activities are associated with osteopenia\/osteoporosis and fracture risk in newly diagnosed type 2 diabetes","volume":"2020","author":"Qiu","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bone.2025.117526_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fendo.2017.00098","article-title":"The impact of glucagon-like Peptide-1 on bone metabolism and its possible mechanisms","volume":"8","author":"Zhao","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada","year":"2008","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0195","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bone.2007.01.007","article-title":"Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass","volume":"40","author":"Xie","year":"2007","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2025.117526_bb0200","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1210\/me.2005-0187","article-title":"Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion","volume":"20","author":"Tsukiyama","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bone.2005.06.021","article-title":"Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover","volume":"37","author":"Xie","year":"2005","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12015-015-9616-6","article-title":"Glucose-dependent Insulinotropic peptide prevents serum deprivation-induced apoptosis in human bone marrow-derived mesenchymal stem cells and osteoblastic cells","volume":"11","author":"Berlier","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3892\/ijmm.2014.1787","article-title":"Expression of glucagon-like peptide-1 receptor and glucose-dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells","volume":"34","author":"Aoyama","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.abb.2010.06.020","article-title":"Feeding and bone","volume":"503","author":"Walsh","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2025.117526_bb0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.peptides.2017.11.023","article-title":"Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: control of the incretin axis and regulation of postprandial glucose and lipid metabolism","volume":"100","author":"Mulvihill","year":"2018","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bone.2025.117526_bb0235","article-title":"The multiple biological functions of dipeptidyl Peptidase-4 in bone metabolism","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3810\/pgm.2013.05.2663","article-title":"Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin","volume":"125","author":"Grunberger","year":"2013","journal-title":"Postgrad. Med."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0245","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00592-018-1271-3","article-title":"Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus","volume":"56","author":"Sesti","year":"2019","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0250","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s13300-020-00819-9","article-title":"Early combination therapy with linagliptin and metformin in people with type 2 diabetes improves glycemic control to HbA1c \u2264 6.5% without increasing hypoglycemia: pooled analysis of two randomized clinical trials","volume":"11","author":"Lv","year":"2020","journal-title":"Diabetes Ther."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.clinthera.2012.02.029","article-title":"Review of linagliptin for the treatment of type 2 diabetes mellitus","volume":"34","author":"Neumiller","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bone.2025.117526_bb0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fendo.2013.00016","article-title":"Linagliptin: a thorough characterization beyond its clinical efficacy","volume":"4","author":"Sortino","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2025.117526_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735824","article-title":"Effects of anti-diabetic drugs on fracture risk: a systematic review and network Meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5582\/ddt.2020.03073","article-title":"Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice","volume":"14","author":"Kanda","year":"2020","journal-title":"Drug Discoveries & Therapeutics"},{"key":"10.1016\/j.bone.2025.117526_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.944323","article-title":"Linagliptin in combination with metformin ameliorates diabetic osteoporosis through modulating BMP-2 and Sclerostin in the high-fat diet fed C57BL\/6 mice","volume":"13","author":"Nirwan","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/VHRM.S1944","article-title":"Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin","volume":"4","author":"Ahr\u00e9n","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0285","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/db13-0805","article-title":"Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and \u201cisoglycemic\u201d intravenous glucose","volume":"63","author":"Vardarli","year":"2014","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.bone.2025.117526_bb0290","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00198-016-3595-6","article-title":"Risk of fractures and diabetes medications: a nationwide cohort study","volume":"27","author":"Choi","year":"2016","journal-title":"Osteoporosis International"},{"issue":"8","key":"10.1016\/j.bone.2025.117526_bb0295","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00198-017-4051-y","article-title":"Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-a retrospective analysis of real-world data","volume":"28","author":"Dombrowski","year":"2017","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0300","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/fcp.12208","article-title":"Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female mice","volume":"30","author":"Kalam","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0305","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S8756-3282(02)00737-8","article-title":"Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers","volume":"30","author":"McLaughlin","year":"2002","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0310","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.bone.2025.117526_bb0315","first-page":"1","article-title":"Development of linagliptin-loaded liposomes using aspartic acid conjugate for bone-targeted delivery to combat osteoporosis","author":"Nirwan","year":"2025","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.bone.2025.117526_bb0320","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0325","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bone.2009.02.017","article-title":"High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice","volume":"44","author":"Cao","year":"2009","journal-title":"Bone"},{"issue":"23","key":"10.1016\/j.bone.2025.117526_bb0330","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1002\/rcm.4316","article-title":"Species identification by analysis of bone collagen using matrix-assisted laser desorption\/ionisation time-of-flight mass spectrometry","volume":"23","author":"Buckley","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.bone.2025.117526_bb0335","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1139\/o76-051","article-title":"Acid phosphatases: androgen dependent markers of rat prostate","volume":"54","author":"Tenniswood","year":"1976","journal-title":"Can. J. Biochem."},{"issue":"17","key":"10.1016\/j.bone.2025.117526_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179476","article-title":"Piezoelectric microvibration mitigates estrogen loss-induced osteoporosis and promotes Piezo1, MicroRNA-29a, and Wnt3a signaling in osteoblasts","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10169","key":"10.1016\/j.bone.2025.117526_bb0345","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0350","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s13300-020-00819-9","article-title":"Early combination therapy with Linagliptin and metformin in people with type 2 diabetes improves glycemic control to HbA1c\u22646.5% without increasing hypoglycemia: pooled analysis of two randomized clinical trials","volume":"11","author":"Lv","year":"2020","journal-title":"Diabetes Therapy"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.0022-3042.2001.00690.x","article-title":"Modulation of a(beta) peptides by estrogen in mouse models","volume":"80","author":"Zheng","year":"2002","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/019262301301418892","article-title":"Ovarian toxicity of 4-vinylcyclohexene diepoxide: a mechanistic model","volume":"29","author":"Hoyer","year":"2001","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12958-021-00799-w","article-title":"Effects of low intensity pulsed ultrasound on expression of B-cell lymphoma-2 and BCL2-associated X in premature ovarian failure mice induced by 4-vinylcyclohexene diepoxide","volume":"19","author":"Xu","year":"2021","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1016\/j.bone.2025.117526_bb0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2016.11.005","article-title":"Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice","volume":"440","author":"Kalam","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0380","first-page":"1633","article-title":"Icariin ameliorates dexamethasone-induced bone deterioration in an experimental mouse model via activation of microRNA-186 inhibition of cathepsin K","volume":"17","author":"Ma","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/me.2002-0210","article-title":"Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells","volume":"17","author":"Zhou","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0390","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00198-016-3839-5","article-title":"Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women","volume":"28","author":"Kim","year":"2017","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0395","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000014","article-title":"Glucocorticoid-induced osteoporosis","volume":"1","author":"Briot","year":"2015","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.bone.2025.117526_bb0400","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/08977190802277880","article-title":"BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization","volume":"26","author":"Luppen","year":"2008","journal-title":"Growth Factors (Chur, Switzerland)"},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0405","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jcp.22145","article-title":"Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway","volume":"224","author":"Huang","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0410","first-page":"2535","article-title":"AMP-activated protein kinase stimulates osteoblast differentiation and mineralization through autophagy induction","volume":"41","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0415","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0420","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1074\/jbc.M406294200","article-title":"Glucocorticoids inhibit the transcriptional activity of LEF\/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner","volume":"280","author":"Smith","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2025.117526_bb0425","series-title":"Endotext","article-title":"Glucocorticoid-induced osteoporosis","author":"Ilias","year":"2000"},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0430","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/1984-0462;2017\/;35;2;00007","article-title":"Glucocorticoid-induced bone disease: mechanisms and importance in pediatric practice","volume":"35","author":"Sarinho","year":"2017","journal-title":"Revista Paulista de Pediatria"},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0435","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jbmr.1773","article-title":"Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels","volume":"28","author":"Jastrzebski","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.bone.2025.117526_bb0440","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","article-title":"Influence of glucocorticoids on human osteoclast generation and activity","volume":"20","author":"Sivagurunathan","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0445","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/en.2010-0456","article-title":"Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells","volume":"152","author":"Rauner","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2025.117526_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00407","article-title":"Sitagliptin, an anti-diabetic drug, suppresses estrogen deficiency-induced osteoporosis in vivo and inhibits RANKL-induced osteoclast formation and bone resorption in vitro","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bone.2025.117526_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109796","article-title":"Anagliptin stimulates osteoblastic cell differentiation and mineralization","volume":"129","author":"Dong","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.bone.2025.117526_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2018.11.008","article-title":"Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway","volume":"216","author":"Zheng","year":"2019","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0465","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00198-013-2371-0","article-title":"The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing","volume":"24","author":"Jeyabalan","year":"2013","journal-title":"Osteoporosis International"},{"issue":"18","key":"10.1016\/j.bone.2025.117526_bb0470","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.12998\/wjcc.v8.i18.4010","article-title":"Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus","volume":"8","author":"Wang","year":"2020","journal-title":"World J. Clin. Cases"},{"issue":"2","key":"10.1016\/j.bone.2025.117526_bb0475","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i2.60","article-title":"The role of BMP2 signaling in the skeleton","volume":"21","author":"Lowery","year":"2011","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/os.12304","article-title":"Prospective review of mesenchymal stem cells differentiation into osteoblasts","volume":"9","author":"Garg","year":"2017","journal-title":"Orthop. Surg."},{"issue":"6","key":"10.1016\/j.bone.2025.117526_bb0485","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcms.2004.06.003","article-title":"Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model","volume":"32","author":"Inoda","year":"2004","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"issue":"1","key":"10.1016\/j.bone.2025.117526_bb0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/me.2002-0210","article-title":"Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells","volume":"17","author":"Zhou","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0495","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/jbmr.3175","article-title":"Bone formation is coupled to resorption via suppression of Sclerostin expression by osteoclasts","volume":"32","author":"Koide","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"issue":"12","key":"10.1016\/j.bone.2025.117526_bb0500","doi-asserted-by":"crossref","first-page":"E2584","DOI":"10.1210\/jc.2013-4493","article-title":"Circulating sclerostin associated with vertebral bone marrow fat in older men but not women","volume":"99","author":"Ma","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2025.117526_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113332","article-title":"The Bromodomain inhibitor N-methyl pyrrolidone prevents osteoporosis and BMP-triggered Sclerostin expression in osteocytes","volume":"19","author":"Siegenthaler","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0510","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"Journal of Bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"10","key":"10.1016\/j.bone.2025.117526_bb0515","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1074\/jbc.RA119.010894","article-title":"Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4","volume":"295","author":"Diaz-Jimenez","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2025.117526_bb0520","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.biopha.2017.10.107","article-title":"The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice","volume":"97","author":"Al Suleimani","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.bone.2025.117526_bb0525","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/ar3379","article-title":"Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors","volume":"13","author":"Zhao","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2025.117526_bb0530","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4","author":"Takayanagi","year":"2002","journal-title":"Arthritis Res."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0535","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2025.117526_bb0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-6-30","article-title":"Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling","volume":"6","author":"Gatson","year":"2009","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0545","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00000658-200011000-00009","article-title":"Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals","volume":"232","author":"Mizushima","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bone.2025.117526_bb0550","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.2147\/DDDT.S249846","article-title":"DPP-4 inhibitor Linagliptin ameliorates oxidized LDL-induced THP-1 macrophage foam cell formation and inflammation","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.bone.2025.117526_bb0555","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:16:44Z","timestamp":1778941004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":111,"alternative-id":["S8756328225001383"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117526","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117526"}}